Clinical trial
Rapid Tranquillization Trial: TREC-India II
NCT00455234 · Christian Medical College, Vellore, India, Other · Completed
Key facts
| NCT number | NCT00455234 |
|---|---|
| Title | Rapid Tranquillization Trial: TREC-India II |
| Official title | Rapid Tranquilization of Violent or Agitated People in Psychiatric Emergency Settings- A Pragmatic Randomized Controlled Trial of Intramuscular Olanzepine Vs. Intramuscular Haloperidol + Promethazine. |
| Acronym | TRECIndia-II |
| Lead sponsor | Christian Medical College, Vellore, India, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psychotic Disorders, Aggression |
| Intervention type | Drug |
| Interventions | Intramuscular Olanzepine 10 mg, Intramuscular Haloperidol 5-10 mg + Promethazine 25-50 mg |
| Enrollment | 300 |
| Start date | Sep 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Apr 3, 2007 |
| Last update posted | Apr 3, 2007 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: